The primary endpoint was defined as the difference in mean weight loss between the two groups at the end of the twelve-month follow-up period
[11] Eli Lilly and Company, 'The Effect of Retatrutide Once Weekly on Cardiovascular Outcomes and Kidney Outcomes in Adults Living With Obesity (TRIUMPH-Outcomes)', ClinicalTrials.gov identifier NCT06383390
Their primary effects include: Glucose-dependent insulin secretion from pancreatic beta cells Suppression of glucagon release from alpha cells Delayed gastric emptying , promoting satiety Central appetite suppression via hypothalamic pathways Reduced energy intake through decreased appetite and earlier satiety These medications produce substantial weight losstypically 10-15% of body weight with semaglutide and up to 20% with tirzepatideprimarily through reduced caloric intake
PubMed , doi:10.1093/carcin/15.5.1073
Symptoms include fatigue, pale skin, headaches, and mood changes
M., Coles, B., Gummerson, N., Sakura, H
